Common Contracts

1 similar Collaboration and Licensing Agreement contracts

Per-target agreement enables Ascidian to pursue additional internal and collaborative programs within neurology and other therapeutic areas
Collaboration and Licensing Agreement • June 10th, 2024

Ascidian’s RNA exon editing platform is designed to advance the therapeutic possibilities of RNA medicine and treat diseases not addressed by today’s gene editing technologies. The company designs and develops RNA exon editing therapeutics that edit RNA exons at the kilobase scale.

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!